Empowered Funds
ALXO icon

Empowered Funds’s ALX Oncology ALXO Stock Holding History

Empowered Funds’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$288K Buy
+207,475
New +$401K ﹤0.01% 2056

Other funds holding ALXO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return

Empowered Funds's ALXO Position: Q3 2026 in Review

Empowered Funds opened a new position in ALX Oncology (ALXO) in Q3 2026: 207,475 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #2056 among its holdings.

65 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

  • Empowered Funds held 207,475 shares of ALX Oncology worth $288K as of Q3 2026.
  • ALX Oncology was a new Empowered Funds position in Q3 2026.
  • ALX Oncology made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2056 holding.
  • 65 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.